They Will Never Forget How You Made Them Feel: Implementing Harm Reduction in the Perinatal Setting

Author:

Puccio JoelleORCID

Abstract

AbstractHarm reduction is a framework built upon respect for people who use drugs. Pregnancy is a priceless window of opportunity for positive change, when parents are driven to improve their health and well-being for their future child, and harm reduction can provide direction for this motivation. Perinatal harm reduction can include goals of abstinence, decreased use, safer use, or a goal unrelated to substance use, such as obtaining housing or employment. We engage in harm reduction, not only by promoting beneficial practices, but by eliminating harmful ones. Despite the science, effective program models, and overwhelming agreement that substance use disorder is a health condition and not deviant behavior, harm reduction programs for pregnant and parenting people are rare, and punitive treatment is the norm. To achieve equitable treatment for people with perinatal substance use disorder and protect the parent-infant dyad, we must stop harmful practices, respect the autonomy of people who use drugs, and address substance use disorders while increasing access to the social determinants of health.

Funder

Health Resources and Services Administration

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health,Epidemiology

Reference17 articles.

1. Academy of Perinatal Harm Reduction. (2019). Harm reduction in practice. APHR. Retrieved March 17, 2023, from https://www.perinatalharmreduction.org/harm-reduction-in-practice

2. American College of Obstetricians and Gynecologists (ACOG). (2011, January). Substance abuse reporting and pregnancy: The role of the obstetrician–gynecologist. Committee Opinion. ACOG. Retrieved March 1, 2023, from https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2011/01/substance-abuse-reporting-and-pregnancy-the-role-of-the-obstetrician-gynecologist

3. Bruzelius, E., & Martins, S. S. (2022). U.S. trends in drug overdose mortality among pregnant and postpartum persons, 2017–2020. JAMA, 328(21), 2159–2161. https://doi.org/10.1001/jama.2022.17045)

4. El-Mohandes, A., Herman, A. A., Nabil El-Khorazaty, M., Katta, P. S., White, D., & Grylack, L. (2003). Prenatal care reduces the impact of illicit drug use on perinatal outcomes. Journal of Perinatology : Official Journal of the California Perinatal Association, 23(5), 354–360. https://doi.org/10.1038/sj.jp.7210933

5. Gage, S. H., & Sumnall, H. R. (2019). Rat Park: How a rat paradise changed the narrative of addiction. Addiction (abingdon, England), 114(5), 917–922. https://doi.org/10.1111/add.14481

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3